Infliximab in the treatment of adult Still's disease refractory to conventional therapy

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Infliximab in the treatment of adult Still's disease refractory to conventional therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences